Mentice AB

Equities

MNTC

SE0012673291

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Stockholm Other stock markets 03:50:40 2024-04-30 am EDT			5-day change	1st Jan Change
35.6 ^SEK	-0.84%		-6.81%	-25.37%

Apr. 02	Mentice Receives an Order of USD 795,000 for Development Services from A World-Leading Medtech Company	CI
Mar. 21	Transcript : Mentice AB - Analyst/Investor Day

Mentice receives an order of USD 795,000 for development services from a world-leading MedTech company

April 02, 2024 at 02:31 am EDT

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare technology leader and existing customer of Mentice has signed an agreement to acquire Mentice VIST® development services for USD 795,000.

“This order represents further support for improved patient safety from one of our largest global customers where investment in advanced training solutions are a strategic part of implementation and adoption of new medical device solutions”, states Göran Malmberg, CEO of Mentice AB.

The order will be recognized for the Medical Device Industry business area during the first quarter of 2024, and most of the revenues will be recognized in 2024.

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Latest news about Mentice AB

Mentice Receives an Order of USD 795,000 for Development Services from A World-Leading Medtech Company	Apr. 02	CI
Transcript : Mentice AB - Analyst/Investor Day	Mar. 21
Mentice AB and Unicen Announce Collaboration to Advance Cardiovascular Healthcare Technologies	Feb. 21	CI
Transcript : Mentice AB, Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Mentice AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI
Mentice’s Ankyras Software Gains US FDA Clearance; Shares Up	Jan. 04	MT
Mentice Receives FDA 510(K) Clearance for Ankyras	Jan. 04	CI
Mentice Receives an Order of Eur 1,733,200 for Simulation Solutions from a World Leading MedTech Company	Dec. 22	CI
Mentice AB (OM:MNTC) agreed to acquire All substantial assets from SIMARATO SAS for ?0.2 million.	Dec. 10	CI
Medical Simulations Group Mentice Names New CFO	Nov. 22	MT
Mentice Appoints Ulrika Drotz Voksepp as New Chief Financial Officer, Effective January 2, 2024	Nov. 22	CI
Mentice AB Announces Board Appointments	23-10-30	CI
Transcript : Mentice AB, Q3 2023 Earnings Call, Oct 26, 2023	23-10-26
Mentice AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Mentice Receives an Order of 1,008,000 for Simulation Solutions from A Medtech Company	23-10-04	CI
Sweden’s Mentice Receives New Order From Asia Pacific Distributor	23-09-20	MT
Mentice AB Receives Significant Order from Key Distributor in APAC	23-09-20	CI
Mentice Appoints Former Volvo Group Exec as COO	23-09-08	MT
Mentice AB Appoints of Jonatan Sjöström to Its Executive Management Group as Chief Operating Officer, Effective from September 14, 2023	23-09-08	CI
Sweden's Mentice Names Interim CFO	23-07-20	MT
Transcript : Mentice AB, H1 2023 Earnings Call, Jul 20, 2023	23-07-20
Mentice AB Announces Chief Financial Officer Changes	23-07-20	CI
Mentice AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-20	CI
Mentice, Siemens Healthineers Expand Business Partnership Deal in China	23-06-29	MT
Mentice AB Expands Cooperation in China with Siemens Healthineers Gothenburg, Sweden	23-06-29	CI

Chart Mentice AB

Duration

Period

More charts

Company Profile

Mentice AB is a Sweden-based medical technology company. It provides software and hardware simulation solutions and related services for endovascular therapies. The Companyâs solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The Companyâs solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. The Company also covers neurovascular, cardiovascular and peripheral interventions, among others. It is active globally.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-03 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Mentice AB

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

35.9 SEK

Average target price

55.33 SEK

Spread / Average Target

+54.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
MENTICE AB	-25.37%	83.99M
SHOCKWAVE MEDICAL, INC.	+72.92%	12.36B
PENUMBRA, INC.	-19.68%	7.83B
MASIMO CORPORATION	+16.20%	7.21B
GETINGE AB	+4.77%	5.97B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+7.49%	5.14B
APT MEDICAL INC.	+23.97%	4.43B
ASAHI INTECC CO., LTD.	-18.81%	3.9B
INARI MEDICAL, INC.	-41.54%	2.2B
SKAN GROUP AG	+1.61%	2.02B

Medical Equipment